Papers
1
Total Citations
5
H-Index
1
About
Yongzhou Li is a leading figure in the advancement of minimally invasive hepatobiliary surgery, with a primary research focus on comparing robotic-assisted and laparoscopic techniques for benign gallbladder disease. His major contribution lies in providing high-quality, evidence-based clarity through rigorous systematic reviews and meta-analyses, most notably in his 2025 landmark study examining robotic-assisted cholecystectomy (RAC) versus conventional and single-incision laparoscopic cholecystectomy (CLC/SILC). This work, already garnering 5 citations shortly after publication, critically evaluates the controversial debate surrounding the true benefits of robotic platforms in routine gallbladder surgery. By synthesizing outcomes on operative time, complications, and recovery, Li’s research helps surgeons and policymakers make informed decisions about adopting new technologies. His work is distinguished by its methodological rigor and direct clinical relevance, addressing a key question in modern surgical practice. As a rising voice in surgical outcomes research, Yongzhou Li continues to shape the conversation on how innovation can be balanced with proven effectiveness, making his contributions essential reading for students and clinicians navigating the evolving landscape of minimally invasive surgery.
Research Focus
Key Achievements
Top Papers
- 1